BR112018072498A2 - marcadores de câncer do endométrio - Google Patents

marcadores de câncer do endométrio

Info

Publication number
BR112018072498A2
BR112018072498A2 BR112018072498A BR112018072498A BR112018072498A2 BR 112018072498 A2 BR112018072498 A2 BR 112018072498A2 BR 112018072498 A BR112018072498 A BR 112018072498A BR 112018072498 A BR112018072498 A BR 112018072498A BR 112018072498 A2 BR112018072498 A2 BR 112018072498A2
Authority
BR
Brazil
Prior art keywords
endometrial cancer
cancer markers
diagnosing
present
mmp9
Prior art date
Application number
BR112018072498A
Other languages
English (en)
Inventor
Lesur Antoine
gil moreno Antonio
Domon Bruno
Martinez García Elena
Colás Ortega Eva
Reventós Puigjaner Jaume
Original Assignee
Fundacio Hospital Univ Vall Dhebron Institut De Recerca
Inst De Recerca Biomedica De Lleida Fundacio Dr Pifarre
Luxembourg Inst Of Health Lih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Hospital Univ Vall Dhebron Institut De Recerca, Inst De Recerca Biomedica De Lleida Fundacio Dr Pifarre, Luxembourg Inst Of Health Lih filed Critical Fundacio Hospital Univ Vall Dhebron Institut De Recerca
Publication of BR112018072498A2 publication Critical patent/BR112018072498A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Abstract

a presente invenção proporciona um método de diagnóstico ou prognóstico de carcinoma endometrial, compreendendo o método de determinar o nível de expressão de mmp9 em uma amostra de fluido aspirado uterino do trato genital feminino. a presente invenção ainda proporciona kits para o diagnóstico da doença.
BR112018072498A 2016-05-04 2017-03-30 marcadores de câncer do endométrio BR112018072498A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16168328 2016-05-04
PCT/EP2017/057635 WO2017190896A1 (en) 2016-05-04 2017-03-30 Mmp9 as marker of endometrial cancer

Publications (1)

Publication Number Publication Date
BR112018072498A2 true BR112018072498A2 (pt) 2019-03-12

Family

ID=56096908

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018072498A BR112018072498A2 (pt) 2016-05-04 2017-03-30 marcadores de câncer do endométrio

Country Status (10)

Country Link
US (2) US20190137499A1 (pt)
EP (2) EP4180814A3 (pt)
JP (2) JP7240712B2 (pt)
AU (2) AU2017260806B9 (pt)
BR (1) BR112018072498A2 (pt)
CA (1) CA3022586A1 (pt)
DK (1) DK3452829T3 (pt)
FI (1) FI3452829T3 (pt)
PT (1) PT3452829T (pt)
WO (1) WO2017190896A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019016400A1 (en) * 2017-07-21 2019-01-24 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca CTNB1 AS A MARKER FOR CANCER OF THE ENDOMETER
AU2022315559A1 (en) 2021-07-23 2024-02-15 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Biomarkers for endometrial cancer
CN113493838B (zh) * 2021-09-06 2021-11-23 北京泱深生物信息技术有限公司 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用
KR102640230B1 (ko) * 2021-09-24 2024-02-22 가천대학교 산학협력단 C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
WO2008003024A2 (en) * 2006-06-28 2008-01-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
CN102549169B (zh) * 2009-07-24 2016-02-24 吉第克生物技术有限公司 子宫内膜癌的标记物

Also Published As

Publication number Publication date
JP2019516104A (ja) 2019-06-13
WO2017190896A1 (en) 2017-11-09
DK3452829T3 (da) 2024-03-25
EP3452829B1 (en) 2024-01-24
EP3452829A1 (en) 2019-03-13
EP4180814A3 (en) 2023-07-12
US20230221323A1 (en) 2023-07-13
CA3022586A1 (en) 2017-11-09
AU2017260806B9 (en) 2023-07-20
AU2023210591A1 (en) 2023-08-24
FI3452829T3 (fi) 2024-03-20
AU2017260806B2 (en) 2023-06-15
EP4180814A2 (en) 2023-05-17
JP7240712B2 (ja) 2023-03-16
PT3452829T (pt) 2024-03-22
US20190137499A1 (en) 2019-05-09
AU2017260806A1 (en) 2018-12-13
JP2023040246A (ja) 2023-03-22

Similar Documents

Publication Publication Date Title
BR112018072498A2 (pt) marcadores de câncer do endométrio
EA201791578A1 (ru) Панель биомаркеров для обнаружения рака
BR112016027939B8 (pt) Sistemas e métodos incluindo uma válvula rotativa para pelo menos um entre preparação de amostra ou análise de amostra
BR112016010106A2 (pt) ensaios para igfbp7 com melhor desempenho em amostras biológicas
GB2556004A (en) Markers of stroke and stroke severity
BR112014031365A2 (pt) métodos de detectar doenças ou condições
FR3023617B1 (fr) Dispositif non invasif de determination de la fertilite et/ou du sexe d’un oeuf, et procede correspondant.
BR112015015086A2 (pt) calibração de válvula de fluido acústico
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
BR112016002845A2 (pt) composições e métodos para tratar condições associadas ao complemento
EP3165923A4 (en) Marker, immunoassay method, immunoassay reagent, method for assaying analyte, kit for assaying analyte, and test strip for lateral flow chromatography
CO2019002607A2 (es) Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activación por contacto
CO2019011359A2 (es) Sistema para predecir el pronóstico y beneficio de una quimioterapia adyuvante para pacientes con cáncer gástrico en estadio ii y iii
UY36200A (es) Conjunto de biomarcadores específicos para diagnóstico no invasivo de cáncer de hígado
BR112019005172A2 (pt) método e kit para analisar uma amostra
BR112018067990A2 (pt) cromogranina a como um marcador para câncer de bexiga
EP3693742A3 (en) Methods of detecting prostate cancer
BR112016029562A2 (pt) métodos para tratar, diagnosticar e prognosticar uma malignidade hematológica
EP4220171A3 (en) Markers for endometrial cancer
BR112019001712A2 (pt) uso de um biomarcador, e, método para avaliar se o indivíduo tem um carcinoma
JP2019516104A5 (pt)
BR112015027249A2 (pt) método de diagnóstico de câncer
CO2019002599A2 (es) Biomarcadores proteicos para enfermedades asociadas con el sistema de activación por contacto
BR112016004374A2 (pt) “dispositivo de diagnóstico para a detecção de estruturas alvo relacionadas a doenças”
BR112018071395A2 (pt) métodos de identificação de pacientes, método de previsão do risco de progressão para lvh, método de diferenciação em pacientes, métodos de previsão se pacientes se encontram com risco de progressão para lvh e uso

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (ES)

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122023026792-3 PROTOCOLO 870230111943 EM 19/12/2023 11:37.